Author:
Moja Lorenzo,Lucenteforte Ersilia,Kwag Koren H,Bertele Vittorio,Campomori Annalisa,Chakravarthy Usha,D'Amico Roberto,Dickersin Kay,Kodjikian Laurent,Lindsley Kristina,Loke Yoon,Maguire Maureen,Martin Daniel F,Mugelli Alessandro,Mühlbauer Bernd,Püntmann Isabel,Reeves Barnaby,Rogers Chris,Schmucker Christine,Subramanian Manju L,Virgili Gianni
Reference31 articles.
1. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers;Akl;PLoS One,8
2. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD;Avery;British Journal of Ophthalmology
3. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion;Braithwaite;Cochrane Database of Systematic Reviews,2014
4. Ranibizumab and bevacizumab for neovascular age-related macular degeneration;Martin;New England Journal of Medicine,2011
5. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial;Chakravarthy;Lancet,2013
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献